Gründungsjahr:
2021
Mitarbeiter:
1-10
Firmenseite:
Zur Website
Expansion:
national
KHR Biotec GmbH is a pharmaceutical biotech company and a spin-off of the Johannes Gutenberg University Mainz. Our
goal is to develop novel therapeutics by elucidating the complex signaling mechanisms underlying major diseases. We aim to develop novel therapeutics related to precision oncology. We are embedded in the well-structured research laboratories of the University Medicine Mainz with the intention to expand our activities in the coming years. Our international research team is led by experienced and respected experts with interdisciplinary expertise in basic and translational medicine.
Join us and become part of our growing team - united by the goal of meeting the unmet medical needs of patients.